Author:
Ayerdi Oskar,Orviz Eva,Valls Carbó Adrián,Fernández Piñeiro Nuria,Vera García Mar,Puerta López Teresa,Ballesteros Martín Juan,Rodríguez Martín Carmen,Baza Caraciolo Begoña,Lejarraga Cañas Clara,Pérez-García Jorge-Alfredo,Carrió Dulce,García Lotero Mónica,Ferreras Forcada María,González Polo Montserrat,Raposo Utrilla Montserrat,Delgado-Iribarren Alberto,Del Romero-Guerrero Jorge,Estrada Pérez Vicente
Reference28 articles.
1. ONUSIDA. Prevención del VIH para 2025 - Hoja de ruta - En marcha para acabar con el sida como amenaza para la salud pública en 2030. 30 de julio de 2022. Available from: https://www.unaids.org/sites/default/files/media_asset/prevention-2025-roadmap_es.pdf.
2. U.S. Department of Health & Human Services /U.S. Food & Drug Administration. Truvada for PrEP Fact Sheet: Ensuring Safe and Proper Use. 2012. Available from: https://www.fda.gov/files/drugs/published/Truvada-for-PrEP-Fact-Sheet--Ensuring-Safe-and-Proper-Use.pdf.
3. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial;McCormack;Lancet Lond Engl,2016
4. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study;Molina;Lancet HIV,2017
5. Preexposure prophylaxis for the prevention of HIV infection in the United States – 2017 update a clinical practice guideline. Cent Dis Control Ad Prev CDC. 2014. Available from: https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf.